Abstract:Takotsubo syndrome (TTS), commonly perceived as a benign and reversible condition has received attention due to emerging registry data revealing its prognosis to be comparable to acute coronary syndrome (ACS). Following ACS, a notable subset of patients develops autonomic dysfunction, whith unfavourable prognostic implications. Periodic repolarization dynamics (PRD) and deceleration capacity (DC), derived from ECG signals, are parameters capable of quantifying cardiac autonomic function. In this study, we aimed to assess autonomic dysfunction in patients with TTC in comparison to ST-elevation myocardial infarction (STEMI) patients. Consecutive patients diagnosed with TTS were prospectively recruited into an observational, single-centre cohort study. All patients underwent a 30-minute high-resolution ecg recording. Subsequent recordings were conducted at 4 and 12 months post-acute event. PRD and DC as markers for sympathetic and parasympathetic activity, respectively, were assessed using established methods. The control group comprised patients with STEMI. Statistical comparisons between groups were performed using the Mann-Whitney U-test, with a corrected significance level for multiple testing of α< .017. Between July 2021 and December 2023, 57 patients diagnosed with TTS were recruited (interquartile range [IQR]) 69.0 years (62.0-78.0), 98.3% women. A control group was derived from a pre-existing cohort of STEMI patients, matched through propensity score matching to adjust for age and sex (median age [IQR]: 69.0 [59.0-76.0] years, 98.3% women). At baseline, there was no significant difference in PRD between TTS patients and controls (median [IQR]: TTS: 5.28deg2 [3.43-9.93], STEMI: 4.40deg2 [2.24-7.21]; p = .04). However, at 4 months post-acute event, PRD was notably higher in TTS patients compared to controls (median [IQR]: TTS: 5.20deg2 [2.71-8.17], STEMI: 2.63deg2 [1.86-4.92]; p = .011). Interestingly, at 12-month follow-up, PRD in TTS patients did not differ from that of controls (median [IQR]: TTS: 4.55deg2 [2.89-8.40], STEMI: 4.15deg2 [2.42-6.85]; p = .68). Regarding DC, no significant differences were observed between TTS and STEMI patients at any time point (baseline: median [IQR]: TTS: 3.95 ms [2.27-5.51], STEMI: 3.52 ms [2.30-7.24], p = .51; 4 months: median [IQR]: TTS: 6.63 ms [4.59-8.64], STEMI: 7.41 ms [4.63-9.25], p = .39; 12 months: median [IQR]: TTS: 4.98 ms [4.19-6.67], STEMI: 7.48 ms [4.92-10.28], p = .17). Patients with TTS show substantial signs of cardiac autonomic dysfunction, similar or even higher than acute STEMI patients. This dysfunction persists even up to 4 months after the acute event, whereas STEMI patients show recovery of autonomic function in this 4 month period. DC remained consistent between TTS and STEMI patients across all time points. Further research elucidating the long-term implications of these autonomic alterations is warranted to refine risk stratification and therapeutic strategies in TTS management.

Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort

Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo Syndrome

Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry

Peripartum Takotsubo Cardiomyopathy: A Review and Insights from a National Registry

Pediatric takotsubo cardiomyopathy: A review and insights from a National Multicentric Registry

Neurological Disorders in Takotsubo Syndrome: Clinical Phenotypes and Outcomes

Cardiac autonomic dysfunction in Takotsubo cardiomyopathy: an observational study

Angiography derived index of microvascular resistance (IMR) in Takotsubo syndrome

Evaluation of Recurrent Takotsubo Syndrome

Takotsubo Syndrome: impact of medical therapies on prognosis. A state of art review

Racial and Ethnic Disparities in Clinical Outcomes among Patients with Takotsubo Syndrome; A Nation-Wide Analysis

Takotsubo syndrome outcomes predicted by thyroid hormone signature: insights from cluster analysis of a multicentre registry

Noninvasive Assessment in Takotsubo Syndrome: A Diagnostic Challenge

TakoTsubo Syndrome: A Well-Known Disease but Not Everything Is Clear Yet

Coronary microvascular dysfunction in Takotsubo syndrome: an analysis using angiography-derived index of microcirculatory resistance

Epidemiology, Diagnosis, and Treatment of Takotsubo Syndrome: a Comprehensive Review

Temporal Trends in Takotsubo Syndrome: Results From the International Takotsubo Registry

Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry

Long-Term Functional Limitations on Cardiopulmonary Exercise Testing in Emotion-Triggered Takotsubo Syndrome

Prediction of in-hospital complications in takotsubo syndrome: prospective cohort study

Takotsubo cardiomyopathy in patients suffering from acute non-traumatic subarachnoid hemorrhage—A single center follow-up study